Uflex (500148) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
19 Nov, 2025Executive summary
FY25 marked a turnaround with revenue, volumes, and operational EBITDA all increasing year-over-year, reversing prior declines and driven by global expansion and sustainability initiatives.
Exceptional losses dropped significantly, leading to a consolidated net profit after tax of Rs. 14,232 lacs, compared to a net loss of Rs. 69,099 lacs in FY24.
Major capex in Egypt, Mexico, and India expanded aseptic packaging, WPP bags, and recycling infrastructure.
Dividend of Rs. 3 per share (30%) recommended for FY25, subject to shareholder approval.
Management expects robust FY26, led by demand for sustainable packaging and technological advancements.
Financial highlights
Consolidated FY25 revenue was Rs. 1,503,609 lacs, up from Rs. 1,336,363 lacs in FY24, with packaging films surpassing 500,000 tons in production and sales.
Operational EBITDA increased by about 18% year-over-year, reaching Rs. 97,629 lacs.
CapEx for FY25 totaled Rs. 17,258 million, with major investments in aseptic packaging and WPP projects.
Net debt as of March 2025 was Rs. 68,432 million; net debt/normalized EBITDA at 3.60x.
Basic and diluted EPS (consolidated) for FY25 was Rs. 19.71, compared to Rs. (95.69) in FY24.
Outlook and guidance
FY26 is expected to benefit from new project commissions in Mexico, Egypt, and Noida, with strong demand for sustainable packaging films and flexible solutions.
Revenue is projected to grow by 10% to INR 16,700 crore, with EBITDA margins expected at 12.5%-13%, targeting INR 2,100 crore EBITDA.
Aseptic packaging volume guidance for FY26 is 10-10.5 billion packs.
CapEx for FY26 is planned at around INR 1,200 crore, with debt repayments of INR 1,175 crore.
Management foresees growth from bioplastics, emerging markets, and innovative packaging technologies.
Latest events from Uflex
- 9MFY26 revenue up 0.8% YoY; Q3 down on weak volumes, but capex and sustainability to drive growth.500148
Q3 25/2616 Feb 2026 - Double-digit revenue and EBITDA growth, margin expansion, and strong outlook despite currency losses.500148
Q1 24/252 Feb 2026 - Strong revenue growth and global expansion offset by margin pressures from currency losses.500148
Q2 24/2513 Jan 2026 - Q1 FY26 revenue and profit rose, with expansion and regulatory shifts driving future growth.500148
Q1 25/2623 Nov 2025 - Q3 FY25 delivered strong growth, margin gains, and major investments for future expansion.500148
Q3 24/2521 Nov 2025 - Q2 FY26 saw flat revenue, modest profit, and new capacity expansion amid regulatory headwinds.500148
Q2 25/2614 Nov 2025